Chest health - Facing cancer head-on: Local young mother tries to stay positive in battle for life

Facing cancer head-on: Local young mother tries to stay positive in battle for life
Post-Star - Feb 07 6:02 AM
Too much life radiates from Kelly Mulholland's sparkling brown eyes, glossy hair, and full-wattage smile for a woman who has been told she is dying. Breast cancer is trying to take over her body, but it's up against a steely sense of optimism.Save to My Web

Cell Therapeutics gets FDA OK to fast-track cancer drug
bizjournals.com via Yahoo! Finance - Feb 08 2:07 PM
Cell Therapeutics Inc.'s Xyotax cancer drug for women has received fast-track designation from the U.S. Food and Drug Administration.Save to My Web

18 Houston ZIPs see rise in lung cancer rates
Houston Chronicle - Feb 04 11:10 PM
When 68-year-old Lucie Wood tells someone that she is battling lung cancer, she is irritated that most automatically assume she is a smoker. Terri Diaz, who contracted lung cancer three years ago at 41, also has grown tired of her illness being stigmatized as a "smoker's disease." Save to My Web

Top Cancer Experts Gather at NCCN 11th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care(TM)
[Press Release] Business Wire via Yahoo! Finance - Feb 07 6:55 AM
JENKINTOWN, Pa.----Feb. 7, 2006--With significant advances in cancer research and care, what can the medical community, patients and healthcare payors expect now and anticipate in the future?Save to My Web

Lung Cancer Is 'Poor Relation' In Care
Sky News via Yahoo! UK & Ireland News - Feb 06 8:05 PM
Lung cancer is the UK's biggest cancer killer but sufferers are still not getting the care and attention they deserve, campaigners say.Patients who want more done to combat the disease are today handing the first Lung Cancer Patients Charter to the Government to set minimum standards for treatment.Save to My Web

XYOTAX(TM) has FDA Fast Track Designation for Women With Advanced Lung Cancer Who are Performance Status 2
[Press Release] PR Newswire via Yahoo! Finance - Feb 08 4:00 AM
Cell Therapeutics, Inc. announced that the U.S. Food and Drug Administration confirmed that XYOTAX, a novel biologically-enhanced version of one of the most used cancer drugs, Taxol , qualifies for fast track designation for the treatment of PS2 women with first-line advanced non-small cell lung cancer , which is currently being studied in the PIONEER clinical trial.Save to My Web